{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:08:21Z","timestamp":1748664501604,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"DOI":"10.7759\/cureus.85087","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T13:52:58Z","timestamp":1748613178000},"source":"Crossref","is-referenced-by-count":0,"title":["Zoledronic Acid in the Treatment of Primary Knee Osteoarthritis: A Randomized Clinical Trial"],"prefix":"10.7759","author":[{"given":"Toufiqe","family":"Ealahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Abul Kalam","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Nazrul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Masudul","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nira","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhana Binty","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Tazbir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100587","article-title":"Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies","volume":"29-30","author":"Cui A","year":"2020","unstructured":"Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020, 29-30:100587. 10.1016\/j.eclinm.2020.100587","journal-title":"EClinicalMedicine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2321","article-title":"Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis","volume":"375","author":"da Costa BR","year":"2021","unstructured":"da Costa BR, Pereira TV, Saadat P, et al.. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021, 375:n2321. 10.1136\/bmj.n2321","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou R","year":"2015","unstructured":"Chou R, Turner JA, Devine EB, et al.. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015, 162:276-86. 10.7326\/M14-2559","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jfmk6010015","article-title":"Intra-articular injections in knee osteoarthritis: a review of literature","volume":"6","author":"Testa G","year":"2021","unstructured":"Testa G, Giardina SM, Culmone A, Vescio A, Turchetta M, Cannav\u00f2 S, Pavone V. Intra-articular injections in knee osteoarthritis: a review of literature. J Funct Morphol Kinesiol. 2021, 6:10.3390\/jfmk6010015","journal-title":"J Funct Morphol Kinesiol"},{"key":"ref5","article-title":"Treatment of knee osteoarthritis","volume":"1","author":"Ringdahl E","year":"2011","unstructured":"Ringdahl E, Pandit S. Treatment of knee osteoarthritis. Am Fam Phys. 2011, 1:1287-92.","journal-title":"Am Fam Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019190341","article-title":"Intra-articular corticosteroid injections in the hip and knee: perhaps not as safe as we thought?","volume":"293","author":"Kompel AJ","year":"2019","unstructured":"Kompel AJ, Roemer FW, Murakami AM, Diaz LE, Crema MD, Guermazi A. Intra-articular corticosteroid injections in the hip and knee: perhaps not as safe as we thought?. Radiology. 2019, 293:656-63. 10.1148\/radiol.2019190341","journal-title":"Radiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4081\/or.2018.7782","article-title":"Pharmacological treatment of knee osteoarthritis: special considerations of the new German guideline","volume":"10","author":"Steinmeyer J","year":"2018","unstructured":"Steinmeyer J, Bock F, St\u00f6ve J, Jerosch J, Flechtenmacher J. Pharmacological treatment of knee osteoarthritis: special considerations of the new German guideline. Orthop Rev (Pavia). 2018, 10:7782. 10.4081\/or.2018.7782","journal-title":"Orthop Rev (Pavia)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202989","article-title":"Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the osteoarthritis initiative","volume":"73","author":"Laslett LL","year":"2014","unstructured":"Laslett LL, Kingsbury SR, Hensor EM, Bowes MA, Conaghan PG. Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the osteoarthritis initiative. Ann Rheum Dis. 2014, 73:824-30. 10.1136\/annrheumdis-2012-202989","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-015-1316-9","article-title":"Osteoarthritis is what the people have","volume":"93","author":"Luft FC","year":"2015","unstructured":"Luft FC. Osteoarthritis is what the people have. J Mol Med (Berl). 2015, 93:819-21. 10.1007\/s00109-015-1316-9","journal-title":"J Mol Med (Berl)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2005.01.007","article-title":"Tibial cancellous bone changes in patients with knee osteoarthritis. A short-term longitudinal study using Fractal Signature Analysis","volume":"13","author":"Messent EA","year":"2005","unstructured":"Messent EA, Ward RJ, Tonkin CJ, Buckland-Wright C. Tibial cancellous bone changes in patients with knee osteoarthritis. A short-term longitudinal study using Fractal Signature Analysis. Osteoarth Cartil. 2005, 13:463-70. 10.1016\/j.joca.2005.01.007","journal-title":"Osteoarth Cartil"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218089","article-title":"Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis","volume":"80","author":"Hu W","year":"2021","unstructured":"Hu W, Chen Y, Dou C, Dong S. Microenvironment in subchondral bone: predominant regulator for the treatment of osteoarthritis. Ann Rheum Dis. 2021, 80:413-22. 10.1136\/annrheumdis-2020-218089","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121561","article-title":"Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain","volume":"129","author":"Zhu S","year":"2019","unstructured":"Zhu S, Zhu J, Zhen G, et al.. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J Clin Invest. 2019, 129:1076-93. 10.1172\/JCI121561","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2017.11.013","article-title":"Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials","volume":"26","author":"Vaysbrot EE","year":"2018","unstructured":"Vaysbrot EE, Osani MC, Musetti MC, McAlindon TE, Bannuru RR. Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2018, 26:154-64. 10.1016\/j.joca.2017.11.013","journal-title":"Osteoarthritis Cartilage"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2014.09.002","article-title":"A study of the prevalence of osteoporosis and hypovitaminosis D in patients with primary knee osteoarthritis","volume":"5","author":"Ghosh B","year":"2014","unstructured":"Ghosh B, Pal T, Ganguly S, Ghosh A. A study of the prevalence of osteoporosis and hypovitaminosis D in patients with primary knee osteoarthritis. J Clin Orthop Trauma. 2014, 5:199-202. 10.1016\/j.jcot.2014.09.002","journal-title":"J Clin Orthop Trauma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v5.i3.351","article-title":"Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis","volume":"5","author":"Ayhan E","year":"2014","unstructured":"Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World J Orthop. 2014, 5:351-61. 10.5312\/wjo.v5.i3.351","journal-title":"World J Orthop"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001265","article-title":"Development of classification criteria for hand osteoarthritis: comparative analyses of persons with and without hand osteoarthritis","volume":"6","author":"Haugen IK","year":"2020","unstructured":"Haugen IK, Felson DT, Abhishek A, et al.. Development of classification criteria for hand osteoarthritis: comparative analyses of persons with and without hand osteoarthritis. RMD Open. 2020, 6:10.1136\/rmdopen-2020-001265","journal-title":"RMD Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3192-y","article-title":"Development, linguistic and clinimetric validation of the WOMAC VA3.01 Bangla for Bangladesh Index","volume":"35","author":"Rabbani MG","year":"2015","unstructured":"Rabbani MG, Haq SA, Bellamy N, et al.. Development, linguistic and clinimetric validation of the WOMAC VA3.01 Bangla for Bangladesh Index. Rheumatol Int. 2015, 35:997-1003. 10.1007\/s00296-014-3192-y","journal-title":"Rheumatol Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-023-02126-w","article-title":"Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness","volume":"21","author":"Lin DY","year":"2023","unstructured":"Lin DY, Cheok TS, Kaambwa B, et al.. Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness. Health Qual Life Outcomes. 2023, 21:41. 10.1186\/s12955-023-02126-w","journal-title":"Health Qual Life Outcomes"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/BCO.0000000000000639","article-title":"Osteoarthritis of the knee refractory to standard care: comparison of intraarticular hylan G-F 20 with triamcinolone acetonide. A real life study in a developing country","volume":"29","author":"Razzaque M A","year":"2018","unstructured":"Razzaque M A, Islam M N, Devnath N. Osteoarthritis of the knee refractory to standard care: comparison of intraarticular hylan G-F 20 with triamcinolone acetonide. A real life study in a developing country. Curr Orthop. 2018, 29:329-36. 10.1097\/BCO.0000000000000639","journal-title":"Curr Orthop"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.21474\/IJAR01\/3057","article-title":"Alendronate sodium affects anabolic and cartilage degradative markers and clinical activity in osteoarthritis","volume":"5","author":"Kadhim SAA","year":"2017","unstructured":"Kadhim SAA, Jawad HM, Shihab SS. Alendronate sodium affects anabolic and cartilage degradative markers and clinical activity in osteoarthritis. Int J Adv Res. 2017, 5:2653-64. 10.21474\/IJAR01\/3057","journal-title":"Int J Adv Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052767","article-title":"Gender-related aspects in osteoarthritis development and progression: a review","volume":"23","author":"Peshkova M","year":"2022","unstructured":"Peshkova M, Lychagin A, Lipina M, et al.. Gender-related aspects in osteoarthritis development and progression: a review. Int J Mol Sci. 2022, 23:10.3390\/ijms23052767","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/art.42089","article-title":"Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019","volume":"74","author":"Long H","year":"2022","unstructured":"Long H, Liu Q, Yin H, et al.. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Arthritis Rheumatol. 2022, 74:1172-83. 10.1002\/art.42089","journal-title":"Arthritis Rheumatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2020.100085","article-title":"Predominant lifetime occupation and associations with painful and structural knee osteoarthritis: an international participant-level cohort collaboration","volume":"2","author":"Parsons CM","year":"2020","unstructured":"Parsons CM, Gates LS, Perry T, et al.. Predominant lifetime occupation and associations with painful and structural knee osteoarthritis: an international participant-level cohort collaboration. Osteoarthr Cartil Open. 2020, 2:100085. 10.1016\/j.ocarto.2020.100085","journal-title":"Osteoarthr Cartil Open"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-297","article-title":"Independent associations of socioeconomic factors with disability and pain in adults with knee osteoarthritis","volume":"14","author":"Cleveland RJ","year":"2013","unstructured":"Cleveland RJ, Luong ML, Knight JB, Schoster B, Renner JB, Jordan JM, Callahan LF. Independent associations of socioeconomic factors with disability and pain in adults with knee osteoarthritis. BMC Musculoskelet Disord. 2013, 14:297. 10.1186\/1471-2474-14-297","journal-title":"BMC Musculoskelet Disord"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93394-3","article-title":"Effects of education, income, and occupation on prevalence and symptoms of knee osteoarthritis","volume":"11","author":"Lee JY","year":"2021","unstructured":"Lee JY, Han K, Park YG, Park SH. Effects of education, income, and occupation on prevalence and symptoms of knee osteoarthritis. Sci Rep. 2021, 11:13983. 10.1038\/s41598-021-93394-3","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.142323","article-title":"Does smoking protect against osteoarthritis? Meta-analysis of observational studies","volume":"70","author":"Hui M","year":"2011","unstructured":"Hui M, Doherty M, Zhang W. Does smoking protect against osteoarthritis? Meta-analysis of observational studies. Ann Rheum Dis. 2011, 70:1231-7. 10.1136\/ard.2010.142323","journal-title":"Ann Rheum Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/art.22160","article-title":"Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study","volume":"54","author":"Bingham CO 3rd","year":"2006","unstructured":"Bingham CO 3rd, Buckland-Wright JC, Garnero P, et al.. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum. 2006, 54:3494-507. 10.1002\/art.22160","journal-title":"Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X19880054","article-title":"Zoledronic acid plus methylprednisolone versus zoledronic acid or placebo in symptomatic knee osteoarthritis: a randomized controlled trial","volume":"11","author":"Cai G","year":"2019","unstructured":"Cai G, Laslett LL, Aitken D, et al.. Zoledronic acid plus methylprednisolone versus zoledronic acid or placebo in symptomatic knee osteoarthritis: a randomized controlled trial. Ther Adv Musculoskelet Dis. 2019, 11:1759720X19880054. 10.1177\/1759720X19880054","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/road085","article-title":"Association of\u00a0bisphosphonate with bone loss and\u00a0pain-related behaviour in\u00a0an adjuvant-induced osteoporosis model","volume":"34","author":"Mayumi N","year":"2024","unstructured":"Mayumi N, Wakabayashi H, Miyamura G, Sudo A. Association of\u00a0bisphosphonate with bone loss and\u00a0pain-related behaviour in\u00a0an adjuvant-induced osteoporosis model. Mod Rheumatol. 2024, 34:841-50. 10.1093\/mr\/road085","journal-title":"Mod Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/372351-zoledronic-acid-in-the-treatment-of-primary-knee-osteoarthritis-a-randomized-clinical-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T13:52:59Z","timestamp":1748613179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/372351-zoledronic-acid-in-the-treatment-of-primary-knee-osteoarthritis-a-randomized-clinical-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.85087","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}